Spruce Biosciences Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Spruce Biosciences Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: South SAN Francisco
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: SPRB
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001683553
EIN: 81-2154263

Board of directors

Follow this board

Bali Muralidhar · Director
Since 2023
Camilla Simpson V · Director
Since 2023
Daniel K. Spiegelman · Director Overboarded
Since 2023
Javier B. Szwarcberg · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Keli Walbert · Director
Since 2025
Kirk Ways · Director · Interim Chief Medical Officer
Since 2023
Michael G. Grey · Director · Executive Chairman
Since 2023
Niall O'Donnell · Director
Since 2023
Percival Barretto-Ko · Director
Since 2023
Tiba Aynechi · Director
Since 2023

Chief executives

Javier B. Szwarcberg · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Michael G. Grey

92.1%

Board connections

7 of this board's directors also sit on 9 other boards. 9 are in the same sector.

Shared director Other board Same sector

OnKure Therapeutics Inc. Same sector
via Bali Muralidhar, Michael G. Grey and Niall O'Donnell
GRI Bio Inc. Same sector
via Camilla Simpson V
Hemab Therapeutics Holdings Inc. Same sector
via Keli Walbert
Kyverna Therapeutics Inc. Same sector
via Daniel K. Spiegelman
MBX Biosciences Inc. Same sector
via Tiba Aynechi
Maze Therapeutics Inc. Same sector
via Daniel K. Spiegelman
Mirum Pharmaceuticals Inc. Same sector
via Michael G. Grey
Myriad Genetics Inc. Same sector
via Daniel K. Spiegelman
vTv Therapeutics Inc. Same sector
via Daniel K. Spiegelman

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 30, 2026	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Grant or award	+266	$4.53	$1,205
Dec 31, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Grant or award	+4,690	$4.53	$21,246
Dec 15, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Option exercise	+496	—	—
Dec 15, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Option exercise	+1,480	—	—
Dec 15, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Shares withheld for tax	−178	$80.67	$14,359
Dec 15, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−752	$80.67	$60,664
Dec 15, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Option exercise	+513	—	—
Dec 15, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Option exercise	+1,196	—	—
Dec 15, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Shares withheld for tax	−184	$80.67	$14,843
Dec 15, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−608	$80.67	$49,047
Dec 11, 2025	Kirk Ways Director, Officer (Interim Chief Medical Officer)	Option exercise	+1,250	—	—
Dec 11, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Option exercise	+1,900	—	—
Dec 11, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Option exercise	+4,950	—	—
Dec 11, 2025	Gharib Samir M. Officer (PRESIDENT AND CFO)	Shares withheld for tax	−680	$88.41	$60,119
Dec 11, 2025	Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER)	Shares withheld for tax	−2,194	$88.41	$193,972

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Spruce Biosciences Inc.

Who is the CEO of Spruce Biosciences Inc.?

Javier B. Szwarcberg is Spruce Biosciences Inc.'s Chief Executive Officer.

How many directors are on Spruce Biosciences Inc.'s board?

Spruce Biosciences Inc.'s board has 10 directors: Bali Muralidhar, Camilla Simpson V, Daniel K. Spiegelman, Javier B. Szwarcberg, Keli Walbert, Kirk Ways, Michael G. Grey, Niall O'Donnell, Percival Barretto-Ko and Tiba Aynechi.

How is Spruce Biosciences Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="spruce-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.